Millennium Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-200,000
Closed -$3.8M – 3333
2016
Q1
$3.8M Buy
+200,000
New +$3.95M 0.01% 1412

Other funds holding HRTX

Millennium Management's HRTX Position: Q3 2026 in Review

Millennium Management reduced its Heron Therapeutics (HRTX) stake by 64% in Q3 2026, selling an estimated $989K and leaving 1,459,918 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #5085.

Millennium Management first reported a position in HRTX in Q1 2014 and has held it in 41 quarters since. The position peaked at $23.7M in Q2 2015. 159 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

  • Millennium Management held 1,459,918 shares of Heron Therapeutics worth $458K as of Q3 2026.
  • Millennium Management sold 2,610,183 Heron Therapeutics shares in Q3 2026, an estimated $989K.
  • Heron Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5085 holding.
  • Millennium Management first reported a position in Heron Therapeutics in Q1 2014 and has held it in 41 quarters since.
  • Millennium Management's Heron Therapeutics position peaked at $23.7M in Q2 2015.
  • 159 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.